GlassScriptPhysician profile
Micheal A Ellerman
NPI 1235661117
$1,687.88
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $741 · 2022: $352 · 2023: $466 · 2024: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.59 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $624.65 | 2021-2023 | Aveir, Cardiomems, Assurity |
| Astrazeneca Pharmaceuticals LP | $330.75 | 2021-2024 | Atacand |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $212.12 | 2021-2024 | Lifevest |
| Heartflow, INC. | $151.36 | 2023-2024 | Ffrct |
| Amgen INC. | $125.00 | 2021 | |
| Abiomed | $124.89 | 2023 | Impella |
| Novartis Pharmaceuticals Corporation | $45.14 | 2024 | |
| Cardiva Medical, INC. | $30.23 | 2023 | Cardiva Vascade 6/7f Vcs |
| Alnylam Pharmaceuticals INC. | $23.41 | 2023 | Onpattro |
| Lantheus Medical Imaging, INC. | $20.33 | 2023 | Definity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micheal Ellerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.